Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
drug applications approved by US FDA as of 1 - 15 February 2018 which includes
Entities (NMEs) and new biologics. It does not include Tentative Approvals.
Supplemental approvals may have occurred since the original approval date.
Treatment with bevacizumab for acute-phase retinopathy of prematurity (ROP), compared with laser, is associated with greater incidence of potentially serious and long-term ocular effects as shown by fluorescein angiography (FA), according to a study.
The school-based outdoor promotion programme appears to effectively reduce the myopia change in both myopic and nonmyopic children, with longer time outdoors with lower light intensity, such as in hallways or under trees, exerting a favourable effect, according to a study from Taiwan.
Factors such as obesity, short distance between screening sites and hospital, poor presenting visual acuity in the better eye, and an abnormal macula on fundus photography are all associated with a higher rate of attendance to follow-up ophthalmic care, according to data from the SToP Glaucoma Study.
At the recent Alcon launch symposium of Systane® Hydration in Kuala Lumpur, three prominent speakers shared their experiences on the management of ocular dryness and highlighted the role of the new therapy.
Long-term use of hydroxychloroquine (HCQ) increases the risk of HCQ retinal toxicity, according to a recent study involving the Korean population. Other risk factors include daily HCQ dose and the presence of kidney disease.